Using the Mann–Whitney U test, we discovered that clinical indices related to infection and inflammation, including CRP, lymphocyte count, and procalcitonin, were significantly improved to normal levels in elderly COVID-19 patients who took ARB prior to hospitalization compared to non-antihypertensive drug users (Fig. 2a and Supplementary Table S9). This evidence concerns the gene CRP and COVID-19.